These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1843042)

  • 21. [Bolus fibrinolysis in acute myocardial infarction].
    Zeymer U
    Dtsch Med Wochenschr; 2002 Oct; 127(40):2083-6. PubMed ID: 12373644
    [No Abstract]   [Full Text] [Related]  

  • 22. [European Society of Cardiology guidelines on ST-elevation myocardial infarction: what is new?].
    De Servi S; D'Urbano M
    G Ital Cardiol (Rome); 2009 Jul; 10(7):490-2. PubMed ID: 19761104
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thrombolytic therapy of myocardial infarct. Status after GISSI-2 and ISIS-3].
    Gulba DC; Claus G
    Internist (Berl); 1992 Apr; 33(4):206-15. PubMed ID: 1612844
    [No Abstract]   [Full Text] [Related]  

  • 24. Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must?
    Danchin N
    Eur Heart J; 2005 Mar; 26(6):529-31. PubMed ID: 15713697
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thrombolytic therapy].
    van de Loo J
    Internist (Berl); 1992 Apr; 33(4):195-6. PubMed ID: 1612842
    [No Abstract]   [Full Text] [Related]  

  • 26. Prehospital thrombolysis in acute myocardial infarction.
    Stern R; Arntz HR
    Eur J Emerg Med; 1998 Dec; 5(4):471-9. PubMed ID: 9919456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic assessment between the thrombolysis in 6 hours and delayed thrombolysis after onset of acute myocardial infarction].
    Ren HB; Zhong YG
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):155-7. PubMed ID: 15009962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Improved treatment of myocardial infarction--how has the hospital mortality developed?].
    Reikvam A
    Tidsskr Nor Laegeforen; 1999 Mar; 119(8):1078-9. PubMed ID: 10228406
    [No Abstract]   [Full Text] [Related]  

  • 29. What should a new thrombolytic bring us?
    Verheugt F
    Int J Clin Pract Suppl; 1998 Nov; 99():3-5. PubMed ID: 10344033
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombolysis in acute myocardial infarct].
    Seabra-Gomes R
    Rev Port Cardiol; 1989 Feb; 8(2):81-3. PubMed ID: 2698694
    [No Abstract]   [Full Text] [Related]  

  • 31. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fibrinolytic therapy].
    Beyer J; Schellong S
    Hamostaseologie; 2008 Dec; 28(5):428-37. PubMed ID: 19132172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safe use of thrombolysis in acute myocardial infarction.
    Edhouse J
    J Accid Emerg Med; 1999 Mar; 16(2):159. PubMed ID: 10191465
    [No Abstract]   [Full Text] [Related]  

  • 34. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
    Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
    Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.
    Danchin N; Blanchard D; Steg PG; Sauval P; Hanania G; Goldstein P; Cambou JP; Guéret P; Vaur L; Boutalbi Y; Genès N; Lablanche JM;
    Circulation; 2004 Oct; 110(14):1909-15. PubMed ID: 15451803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotics and antiplatelets in acute myocardial infarction.
    Wander GS; Gupta NK
    Indian Heart J; 2011; 63(1):58-65. PubMed ID: 23189866
    [No Abstract]   [Full Text] [Related]  

  • 37. [The optimization of the results by using thrombolytic therapy in acute myocardial infarct (and II)].
    Cerveró Martí A
    Med Clin (Barc); 1993 Oct; 101(12):464-9. PubMed ID: 8231372
    [No Abstract]   [Full Text] [Related]  

  • 38. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
    Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
    Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of thrombolytic intervention for acute myocardial infarction--is it valuable?
    Talley JD
    J Ark Med Soc; 1994 Jul; 91(2):70-9. PubMed ID: 7928920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.